基于循证医学证据的IgA肾病中西医结合治疗.ppt

;;*;; Cheng J, Zhang X, Zhang W, et al. Efficacy and safety of glucocorticoids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials. Am J Nephrol. 2009;30(4):315-22. ;霉酚酸酯对IgAN蛋白尿的疗效评价;霉酚酸酯对IgAN肾脏替代治疗率的评价;霉酚酸酯对IgAN血肌酐的评价;来氟米特治疗IgA的疗效评价;Ballardie FW, Roberts IS. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.J Am Soc Nephrol. 2002 Jan;13(1):142-8.;Ballardie FW, Roberts IS. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.J Am Soc Nephrol. 2002 Jan;13(1):142-8.;Pozzi C, Andrulli S, Pani A, et al .Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.J Am Soc Nephrol. 2010 Oct;21(10):1783-90 ;Pozzi C, Andrulli S, Pani A, et al .Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.J Am Soc Nephrol. 2010 Oct;21(10):1783-90 ;Cheng J, Zhang X, Zhang W，et al. Efficacy and safety of glucocorticoids therapy for IgA nephropathy: a meta- analysis of randomized controlled trials. Am J Nephrol. 2009;30(4):315-22. ;Cheng J, Zhang X, Zhang W，et al. Efficacy and safety of glucocorticoids therapy for IgA nephropathy: a meta- analysis of randomized controlled trials. Am J Nephrol. 2009;30(4):315-22. ;Taji Y, Kuwahara T, Shikata S, Morimoto T. Meta-analysis of antiplatelet therapy for IgA nephropathy. Clin Exp Nephrol. 2006 Dec;10(4):268-73. ;Taji Y, Kuwahara T, Shikata S, Morimoto T. Meta-analysis of antiplatelet therapy for IgA nephropathy. Clin Exp Nephrol. 2006 Dec;10(4):268-73. ; Miller ER 3rd, Juraschek SP, Appel LJ,et al. The effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: meta-analysis of clinical trials.